Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Ivermectin 1%/Metronidazole 0.75% Topical Gel is a compounded formulation designed for targeted skin treatment. This semisolid medication is dispensed through a pump mechanism, ensuring easy and precise application. The gel-like consistency aids in the absorption of active ingredients for optimal results.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specially compounded topical gel formulation of Ivermectin 1%/Metronidazole 0.75%. This unique combination of medications is designed to address a range of skin conditions, including rosacea, acne, and seborrheic dermatitis. The Ivermectin component works to alleviate inflammation and redness, while the Metronidazole component aids in reducing bacteria and yeast present on the skin.
For patients, this topical gel formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin. It is designed for targeted treatment or absorption of active ingredients in a gel-like consistency. It is crucial to adhere to the instructions provided by your healthcare provider, as incorrect usage of this medication can lead to skin irritation. Please note that this medication may require several weeks to manifest noticeable improvement in your skin condition.
It is essential to monitor patients for any signs of skin irritation or other adverse reactions. If you have any queries about this formulation or its usage, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive information and support to ensure the best possible patient outcomes.
Ivermectin 1%/Metronidazole 0.75% Topical Gel is a specially compounded formulation designed for targeted treatment of specific skin conditions. It is primarily indicated for the management of inflammatory papules and pustules associated with rosacea, a chronic skin disease that causes redness and swelling on the face. This unique combination of ivermectin and metronidazole has demonstrated efficacy in reducing the number of inflammatory lesions and enhancing the overall appearance of the skin.
In addition to its use in treating rosacea, this topical gel is also indicated for the treatment of bacterial vaginosis, a common vaginal infection caused by an imbalance of naturally occurring bacteria. The antimicrobial properties of metronidazole, combined with the anti-parasitic action of ivermectin, work together to combat the infection and restore balance.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. It should be applied twice daily, in the morning and evening, to the affected areas. It is crucial to avoid contact with the eyes, mouth, or mucous membranes. In case of accidental contact, the area should be immediately rinsed with water.
It is important to note that this product is not recommended for use in pregnant or breastfeeding women. As with any medication, it is always advisable to consult with a healthcare provider before starting treatment. If you have any questions or concerns about the use of Ivermectin 1%/Metronidazole 0.75% Topical Gel, please consult with a healthcare professional.
Ivermectin 1%/Metronidazole 0.75% Topical Gel is a compounded formulation designed to treat a variety of skin conditions. This unique combination of two active ingredients, ivermectin and metronidazole, synergistically works to reduce inflammation and eliminate bacteria. The gel is directly applied to the affected skin area, allowing for targeted treatment and efficient absorption of the active ingredients.
This topical gel is used to manage bacterial and fungal skin infections, including conditions like rosacea, acne, and athlete's foot. The gel's semisolid formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin.
When using Ivermectin 1%/Metronidazole 0.75% Topical Gel, it is crucial to adhere to the instructions provided by your healthcare provider. Depending on the severity of the condition, the gel should be applied to the affected skin area once or twice daily. Always remember to wash your hands before and after application and avoid contact with the eyes, nose, and mouth.
While Ivermectin 1%/Metronidazole 0.75% Topical Gel is generally well-tolerated, some individuals may experience side effects such as skin irritation, redness, or a burning sensation. If you encounter any of these side effects, it is advisable to contact your healthcare provider immediately.
If you have any queries about Ivermectin 1%/Metronidazole 0.75% Topical Gel or its usage, please do not hesitate to reach out to us at Bayview Pharmacy. We are committed to assisting you in finding the most suitable treatment for your skin condition.
The Ivermectin 1%/Metronidazole 0.75% Topical Gel is a compounded formulation that has been utilized off-label for the treatment of a wide range of skin conditions. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients.
It has been used to manage parasitic infestations such as scabies and lice, as well as fungal skin infections like tinea versicolor and cutaneous larva migrans. The gel has also shown potential in treating bacterial skin infections, including impetigo, folliculitis, and candidiasis. Furthermore, it has been applied to manage inflammatory skin conditions, such as psoriasis, lichen planus, and atopic dermatitis.
Therefore, it is recommended to consult with a healthcare professional before using this formulation for any of these conditions. This is to ensure that the treatment is suitable for your specific condition and to avoid any potential adverse effects.
This is a compounded formulation of two active ingredients, Ivermectin and Metronidazole, in a gel form. It is designed for topical application on the skin.
This formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The consistency of this topical gel is semisolid, similar to most gel-like substances. This allows it to be easily spread on the skin for targeted treatment.
The active ingredients in this formulation are Ivermectin, which is present at a concentration of 1%, and Metronidazole, which is present at a concentration of 0.75%.
The active ingredients in this formulation work by targeting and treating specific skin conditions. The precise mechanism of action will depend on the condition being treated.
This topical gel should be applied as directed by your healthcare provider. Typically, it is applied to the affected area of the skin in a thin layer.
If you are pregnant or breastfeeding, you should consult your healthcare provider before using this formulation. They will be able to advise you on whether it is safe for you to use.
If you experience any side effects after using this formulation, you should contact your healthcare provider immediately. They will be able to provide you with advice on how to manage these side effects.
Yes, this formulation can be used on the face. However, care should be taken to avoid contact with the eyes and mouth. If the gel does come into contact with these areas, rinse thoroughly with water.
Before using other skincare products in combination with this formulation, it is recommended that you consult your healthcare provider. They will be able to advise you on whether it is safe to do so.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
